Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
Autor: | Jongs, Niels, Greene, Tom, Chertow, Glenn M, McMurray, John J V, Langkilde, Anna Maria, Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C David, Stefansson, Bergur V, Toto, Robert D, Wheeler, David C, Heerspink, Hiddo J L * |
---|---|
Zdroj: | In The Lancet Diabetes & Endocrinology November 2021 9(11):755-766 |
Databáze: | ScienceDirect |
Externí odkaz: |